Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money
Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.
Select the one that best describes you

ARKG
ARK Genomic Revolution ETF

Price: $57.43
Change: $0.61 (0.01%)
Category: Health & Biotech Equities
Last Updated:

Vitals

Investment Themes

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $24.00
  • 52 Week Hi $59.50
  • AUM $1,685.3 M
  • Shares 29.7 M

Analyst Report

The ARK Genomic Revolution ETF (ARKG) is an actively-managed fund from the team at ARK Invest that tries to pick the companies best positioned to profit from advancements in energy, automation, manufacturing, materials and transportation.

The advisory firm, led by Catherine Wood, has an impressive track record doing what most stock pickers fail to do: beating the market.

ARKG invests in companies that could profit from technological and scientific advancements in gene editing, genetic therapy, molecular diagnostics, and stem cell advances.

It’s a niche product without a lot of competition. ARKG’s nearest rival is likely the iShare Genomics immunology and Healthcare ETF, an index-tracking ETF that launched in June 2019.

Beyond the active/passive difference, IDNA’s holdings are dominated by major pharmaceutical firms like Moderna, Regeneron and Gilead Sciences, whereas ARKG’s portfolio is tilted toward significantly smaller firms.

There isn’t a lot of performance history to compare, but it’s worth nothing that IDNA beat ARKG in the first ten weeks of 2020, when global markets were rocked by the coronavirus outbreak and investors were eagerly hunting for potential profit in companies researching treatment and vaccines.

But that’s just a fleeting snapshot during a particularly turbulent time. Any actively-managed product is ultimately a bet on the portfolio managers who pick the stocks. ARK’s products are geared toward investors who have the fortitude and faith to ride out short-term blips in favor of the prospect long-term alpha.

Historical Trading Data

  • 1 Month Avg. Volume 883,491
  • 3 Month Avg. Volume 714,186

Alternative ETFs in the Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $2.0 B 253,291 7.33%
Largest (AUM) XLV 0.13% $24.2 B 10 M 5.16%
Most Liquid (Volume) XLV 0.13% $24.2 B 10 M 5.16%
Top YTD Performer PTH 0.60% $565.1 M 56,848 49.44%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

41
Number of Holdings
57.28%
% Assets in Top 10
71.01%
% Assets in Top 15
100.00%
% Assets in Top 50
 
View Detailed Analysis
 
Number of Holdings
41
Rank
30 of 40
Low
MJJ (22)
High
VHT (425)
% Assets in Top 10
57.28%
Rank
34 of 40
Low
XBI (17.09%)
High
MJJ (77.61%)
% Assets in Top 15
71.01%
Rank
8 of 40
Low
XBI (23.09%)
High
MJJ (90.62%)
% Assets in Top 50
100.00%
Rank
7 of 40
Low
XBI (59.81%)
High
XHS (100.00%)

 
View Summary Analysis
 

Sector Breakdown

Asset Percentage
Common equity 99.74%
ETF Cash Component 0.26%
Sector Percentage
Healthcare 73.97%
Other 23.32%
Technology 2.44%
ETF Cash Component 0.26%
Market Cap Percentage
Micro cap 44.58%
Small cap 26.89%
Mid cap 18.44%
Large cap 9.83%
ETF Cash Component 0.26%
Region Percentage
North America 79.21%
Europe 14.25%
Middle East 6.28%
ETF Cash Component 0.26%
Region Percentage
United States 79.21%
Developed Markets (ex-US) 20.53%
ETF Cash Component 0.26%
Country Percentage
United States 79.21%
Switzerland 11.3%
Israel 6.28%
France 2.95%
ETF Cash Component 0.26%
 
View Less Charts
 
Asset Percentage
Common equity 99.74%
ETF Cash Component 0.26%
 
View More Charts
 

ARKG Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
No Ranking Available
Rank
N/A
Low
PTH (-55.81)
High
PBE (60.68)

ARKG Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$2.11
Dividend Date
2019-12-27
Annual Dividend Rate
$2.11

$2.11
Dividend
2019-12-27
Dividend Date
$2.11
Annual Dividend Rate
Annual Dividend Yield
3.72%
Rank
1 of 28
Low
XBI (0.02%)
High
ARKG (3.72%)

ARKG Fund Flows

View charts featuring ETF fund flow data.

5 Day Net Flows: 8.18 M 1 Month Net Flows: 221.18 M 3 Month Net Flows: 532.98 M 6 Month Net Flows: 706.64 M 1 Year Net Flows: 747.89 M 3 Year Net Flows: 1.13 B 5 Year Net Flows: 1.14 B 10 Year Net Flows: 1.15 B

Realtime Rating

The adjacent table gives investors an individual Realtime Rating for ARKG on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Sign Up for Pro to Unlock Data Sign Up
Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity n/a n/a
Expenses C n/a
Performance
Volatility
Dividend
Concentration

A+ Overall Rated ETF:

ARKG Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.534%
ETF Wtd. Average
0.19%
Category Average
0.47%
Expense Ratio
0.75%
Rank
38 of 40
Low
FHLC (0.08%)
High
BBP (0.79%)
ESG Themes and Scores
2.74/10
ESG Score
3.91%
Global Percentile
0.0%
Peer Percentile
Environmental
Social
Governance
  • Environmental Scores
    • Revenue Exposure to Environmental Impact (%)
      Higher is better, no ESG score impact
    • Severe Environment Controversies (%)
      Lower improves ESG score
    • Sustainable Impact Solutions (%)
      0.39%
      Higher is better, no ESG score impact
    Carbon Intensity
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      24.69
      Higher is worse, no ESG score impact
    Fossil Fuel Reserves
    • Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • High Impact Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    Water Stress
    • Water Stress High Risk Business Segment (%)
      Lower improves ESG score
    • Water Stress High Risk Geography (%)
      Lower improves ESG score
    • Water Stress Exposure Moderate (%)
      Lower improves ESG score
    • Water Stress Exposure High (%)
      Lower improves ESG score
    • Water Stress Exposure Low (%)
      Higher improves ESG score
    Energy Efficiency
    • Revenue Exposure to Energy Efficiency (%)
      Higher is better, no ESG score impact
    Alternative Energy
    • Revenue Exposure to Alternative Energy (%)
      Higher is better, no ESG score impact
    Green Building
    • Revenue Exposure to Green Building (%)
      Higher is better, no ESG score impact
    Pollution Prevention
    • Revenue Exposure to Pollution Prevention (%)
      Higher is better, no ESG score impact
    Water Sustainability
    • Revenue Exposure to Water Sustainability (%)
      Higher is better, no ESG score impact
  • Social Scores
    • Revenue Exposure to Social Impact (%)
      Higher is better, no ESG score impact
    • Sustainable Impact Solutions (%)
      0.39%
      Higher is better, no ESG score impact
    • SRI Exclusion Criteria (%)
      0.04%
      Higher is worse, no ESG score impact
    Affordable Real Estate
    • Revenue Exposure to Affordable Real Estate (%)
      Higher is better, no ESG score impact
    Education
    • Revenue Exposure to Education (%)
      Higher is better, no ESG score impact
    Major Disease Treatment
    • Revenue Exposure to Major Disease Treatment (%)
      Higher is better, no ESG score impact
    Healthy Nutrition
    • Revenue Exposure to Nutrition (%)
      Higher is better, no ESG score impact
    Global Sanitation
    • Revenue Exposure to Sanitation (%)
      Higher is better, no ESG score impact
    SME Finance
    • Revenue Exposure to SME Finance (%)
      Higher is better, no ESG score impact
    Human Rights Violations
    • Human Rights Norms Violation (%)
      Higher is worse, no ESG score impact
    • Human Rights Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Human Rights Controversies (%)
      Lower improves ESG score
    Labor Rights Violations
    • Labor Norms Violation (%)
      Higher is worse, no ESG score impact
    • Labor Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Labor Controversies (%)
      Lower improves ESG score
    Customer Controversies
    • Severe Customer Controversies (%)
      Lower improves ESG score
    UN Principles Violations
    • Global Compact Compliance Violation (%)
      Higher is worse, no ESG score impact
    • Global Compact Compliance Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    Catholic Values
    • Catholic Values Fail (%)
      Higher is worse, no ESG score impact
    Sharia Compliant Investing
    • Islamic Non-Compliant (%)
      Higher is worse, no ESG score impact
    Adult Entertainment
    • Adult Entertainment Involvement (%)
      Higher is worse, no ESG score impact
    Alcohol
    • Alcohol Involvement (%)
      Higher is worse, no ESG score impact
    Gambling
    • Gambling Involvement (%)
      Higher is worse, no ESG score impact
    Nuclear Power
    • Nuclear Power Involvement (%)
      Higher is worse, no ESG score impact
    Tobacco
    • Tobacco Involvement (%)
      Higher is worse, no ESG score impact
    Weapons Involvement
    • Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Controversies Weapons Involvement (%)
      Higher is worse, no ESG score impact
    Firearms
    • Civilian Firearms Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Retailer (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Producer (%)
      Higher is worse, no ESG score impact
    Predatory Lending
    • Direct Predatory Lending Involvement (%)
      Higher is worse, no ESG score impact
    GMO Involvement
    • Genetic Engineering Involvement (%)
      Higher is worse, no ESG score impact
  • Responsible Governance Score
    • Severe Governance Controversies (%)
      Lower improves ESG score
    Board Flag
    • Board Flag (%)
      Lower improves ESG score
    Board Independence
    • Lack of Independent Board Majority (%)
      Lower improves ESG score
    • Board Independence (0-25%) (%)
      Lower improves ESG score
    • Board Independence (25-50%) (%)
      Lower improves ESG score
    • Board Independence (50-75%) (%)
      Higher improves ESG score
    • Board Independence (75-100%) (%)
      Higher improves ESG score
    Board Diversity
    • No Female Directors (%)
      Lower improves ESG score
    • Three OR More Female Directors (%)
      Higher improves ESG score
    • Females Represent 30% of Directors (%)
      Higher improves ESG score
    Entrenched Board
    • Entrenched Board (%)
      Lower improves ESG score
    Overboarding
    • Overboarding (%)
      Lower improves ESG score
    Shareholder Rights
    • Negative Director Votes (%)
      Lower improves ESG score
    • Ownership AND Control Flag (%)
      Lower improves ESG score
    • One Share One Vote (%)
      Lower improves ESG score
    • No Annual Director Elections (%)
      Lower improves ESG score
    • Does Not Use Majority Voting (%)
      Lower improves ESG score
    • Significant Votes Against Pay Practices (%)
      Lower improves ESG score
    Fund Ownership
    • Controlling Shareholder (%)
      Lower improves ESG score
    • Controlling Shareholder Concerns (%)
      Lower improves ESG score
    • Cross Shareholdings (%)
      Lower improves ESG score
    Poison Pill
    • Poison Pill (%)
      Lower improves ESG score
    Executive Compensation
    • Pay Flag (%)
      Lower improves ESG score
    • No Pay Performance Link (%)
      Lower improves ESG score
    • Lack of Internal Pay Equity (%)
      Lower improves ESG score
    • Executive Pay Non-Disclosure (%)
      Lower improves ESG score
    Accounting Flags
    • Accounting Flag (%)
      Lower improves ESG score

ARKG Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

6.25%
1 Week Return
2.28%
4 Week Return
38.15%
13 Week Return
68.47%
26 Week Return
71.33%
Year to Date Return
92.77%
1 Year Return
175.18%
3 Year Return
172.50%
5 Year Return
 
View Detailed Analysis
 
1 Week Return
6.25%
Rank
3 of 39
Low
BBH (-1.61%)
High
PTH (6.92%)
4 Week Return
2.28%
Rank
26 of 39
Low
BBP (-5.71%)
High
XHS (13.35%)
13 Week Return
38.15%
Rank
3 of 38
Low
BBP (0.78%)
High
KMED (46.55%)
26 Week Return
68.47%
Rank
1 of 37
Low
XPH (-6.68%)
High
ARKG (68.47%)
Year to Date Return
71.33%
Rank
1 of 37
Low
XPH (-4.08%)
High
ARKG (71.33%)
1 Year Return
92.77%
Rank
1 of 36
Low
PSCH (12.91%)
High
ARKG (92.77%)
3 Year Return
175.18%
Rank
1 of 29
Low
XPH (7.08%)
High
ARKG (175.18%)
5 Year Return
172.50%
Rank
1 of 25
Low
XPH (-30.85%)
High
ARKG (172.50%)

 
View Summary Analysis
 

ARKG Price and Volume Chart

ARKG Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

 
View Detailed Analysis
 
5 Day Volatility
247.94%
Rank
6 of 39
Low
HTEC (19.99%)
High
SBIO (276.50%)
20 Day Volatility
44.20%
Rank
1 of 39
Low
XLV (12.98%)
High
ARKG (44.20%)
50 Day Volatility
45.64%
Rank
1 of 38
Low
IXJ (18.42%)
High
ARKG (45.64%)
200 Day Volatility
58.22%
Rank
1 of 38
Low
IEIH (32.33%)
High
ARKG (58.22%)
Beta
1.68
Rank
1 of 38
Low
KMED (0.69)
High
ARKG (1.68)
Standard Deviation
8.93%
Rank
13 of 36
Low
FTXH (1.64%)
High
IHI (17.65%)

 
View Summary Analysis
 

Technicals

  • 20 Day MA $56.02
  • 60 Day MA $50.61
  • MACD 15 Period 1.48
  • MACD 100 Period 13.28
  • Williams % Range 10 Day 1.56
  • Williams % Range 20 Day 31.46
  • RSI 10 Day 59
  • RSI 20 Day 59
  • RSI 30 Day 59
  • Ultimate Oscillator 59

Bollinger Brands

  • Lower Bollinger (10 Day) $52.93
  • Upper Bollinger (10 Day) $57.51
  • Lower Bollinger (20 Day) $53.36
  • Upper Bollinger (20 Day) $58.69
  • Lower Bollinger (30 Day) $50.77
  • Upper Bollinger (30 Day) $59.13

Support & Resistance

  • Support Level 1 $56.47
  • Support Level 2 $55.50
  • Resistance Level 1 $57.93
  • Resistance Level 2 $58.42

Stochastic

  • Stochastic Oscillator %D (1 Day) 72.22
  • Stochastic Oscillator %D (5 Day) 66.48
  • Stochastic Oscillator %K (1 Day) 56.79
  • Stochastic Oscillator %K (5 Day) 47.50

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the fact sheet PDF

Brought to You by ETF Flows

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2020 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Help & Info
Tools
More Tools
Explore ETFs
Legal